68070-27-9 Usage
Description
BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer is a complex chemical compound that is part of the porphyrin family. It features a central porphyrin core with four benzene rings attached, creating a tetra-substituted porphyrin structure. As a stereoisomer, it exhibits different spatial arrangements of atoms while maintaining the same chemical formula. Porphyrins are integral to biological systems, functioning as the active site in hemoglobin and chlorophyll, and have a wide range of potential applications in medicine, materials science, and catalysis. The stereoisomeric nature of this compound may influence its reactivity and properties, making it a valuable subject for research in the development of porphyrin-based materials.
Uses
Used in Pharmaceutical Applications:
BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer is utilized as a pharmaceutical agent for its potential therapeutic properties. BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer's unique structure and stereochemistry may contribute to its interactions with biological targets, offering new avenues for drug development.
Used in Materials Science:
In the field of materials science, BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer is employed in the development of advanced materials with specific optical, electronic, or catalytic properties. Its porphyrin-based structure and stereoisomeric variations can lead to novel materials with tailored characteristics for various applications.
Used in Catalysis:
BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer is used as a catalyst or catalyst precursor in chemical reactions. BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer's porphyrin core and benzene substituents can facilitate electron transfer and provide active sites for catalytic processes, making it a promising candidate for applications in catalysis.
Used in Photodynamic Therapy (PDT):
In the medical field, BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer is used as a photosensitizer in photodynamic therapy. BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer's ability to absorb light and generate reactive oxygen species can be harnessed to target and destroy cancer cells, making it a potential treatment option for various types of cancer.
Used in Sensing and Imaging:
BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer is employed in the development of sensing and imaging technologies. Its optical properties and the ability to interact with biological systems can be utilized for detecting and visualizing specific targets, such as disease markers or cellular structures.
Used in Energy Storage and Conversion:
In the field of energy storage and conversion, BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer is used in the design of novel materials for solar cells, batteries, or fuel cells. BenzenaMine, 2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis-, stereoisoMer's electronic properties and porphyrin-based structure can contribute to improved performance and efficiency in energy-related applications.
Check Digit Verification of cas no
The CAS Registry Mumber 68070-27-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,0,7 and 0 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 68070-27:
(7*6)+(6*8)+(5*0)+(4*7)+(3*0)+(2*2)+(1*7)=129
129 % 10 = 9
So 68070-27-9 is a valid CAS Registry Number.
68070-27-9Relevant articles and documents
Spectroscopic investigations into the binding of hydrogen sulfide to synthetic picket-fence porphyrins
Hartle, Matthew D.,Prell, James S.,Pluth, Michael D.
, p. 4843 - 4853 (2016/03/19)
The reversible binding of hydrogen sulfide (H2S) to hemeprotein sites has been attributed to several factors, likely working in concert, including the protected binding pocket environment, proximal hydrogen bond interactions, and iron ligation environment. To investigate the importance of a sterically-constrained, protected environment on sulfide reactivity with heme centers, we report here the reactivity of H2S and HS- with the picket-fence porphyrin system. Our results indicate that the picket-fence porphyrin does not bind H2S in the ferric or ferrous state. By contrast, reaction of the ferric scaffold with HS- results in reduction to the ferrous species, followed by ligation of one equivalent of HS-, as evidenced by UV-vis, NMR spectroscopy and mass spectrometry studies. Measurement of the HS- binding affinities in the picket-fence or tetraphenyl porphyrin systems revealed identical binding. Taken together, these results suggest that the protected, sterically-constrained binding pocket alone is not the primary contributor for stabilization of ferric H2S/HS- species in model systems, but that other interactions, such as hydrogen bonding, must play a critical role in facilitation of reversible interactions in ferric hemes.
